2017年版、2009年版《国家基本医疗保险、工伤保险和生育保险药品目录》西药品种对比分析  

A comparative study between the national basic medical insurance, industrial injury insurance and maternity insurance medicines list in 2017 edition and 2009 edition

作　　者：谭文苗 王强 王兰 蔡彦蓉 

机构地区：[1]北京普瑞快思医药咨询有限公司,北京100020

出　　处：《临床药物治疗杂志》2017年第7期11-17,共7页Clinical Medication Journal

摘　　要：目的:深入了解2017年版《国家基本医疗保险、工伤保险和生育保险药品目录》(以下简称2017年版《药品目录》)西药品种。方法:比较2017年版《药品目录》与2009年版《药品目录》西药品种的差异。利用《医院处方分析合作项目》的处方数据,对2017年版《药品目录》中重点关注的西药品种进行处方金额分析(仅到药品名称层级,不区分剂型)。结果和结论:2017年版《药品目录》明显扩大了基本医疗保险用药保障范围、提高了用药保障水平,有利于减轻广大参保人员目录外药品费用负担,有利于我国医药产业创新发展。Objective： To deeply understand the national basic medical insurance, industrial injury insurance, and maternity insurance medicines list in 2017 edition（hereinafter referred as medicines list in 2017 edition）. Methods： The differences of varieties in medicines list were compared between 2017 edition and 2009 edition. The amount of charges of aimed varieties were analyzed by using the prescription data in hospital prescription analysis cooperative project（only drug name was considered without drug formulations）. Results and Conclusion： The basic medical insurance drug coverage is significantly expand in the medicines list in 2017 edition which easing the burden of personnel drug expenses. The medical security level and the development of pharmaceutical industry in China also improved according to the changes in the medicines list in 2017 edition.

关 键 词：药品目录 对比 处方金额 

分 类 号：R98[医药卫生—药品]